AIIC
AJU IB Investment Company Portfolio holdings
AUM
$91.9M
This Quarter Return
+4.17%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$173M
AUM Growth
+$173M
(-35%)
Cap. Flow
-$20.6M
Cap. Flow
% of AUM
-11.88%
Top 10 Holdings %
Top 10 Hldgs %
99.95%
Holding
11
New
–
Increased
–
Reduced
5
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Seer Inc
SEER
|
$8.2M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$6.53M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$3.16M |
| 4 |
Clearside Biomedical
CLSD
|
$2.44M |
| 5 |
RAPT Therapeutics
RAPT
|
$286K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apellis Pharmaceuticals
APLS
$3.48B
| $67.3M | 38.81% | 1,064,962 -50,000 | -4% | -$3.16M |
|
|
2
Atea Pharmaceuticals
AVIR
$267M
| $37.5M | 21.62% | 1,745,331 -304,000 | -15% | -$6.53M |
|
3
Kymera Therapeutics
KYMR
$2.95B
| $31M | 17.87% | 639,059 | – | – |
|
|
4
Seer Inc
SEER
$115M
| $26.8M | 15.43% | 816,375 -250,000 | -23% | -$8.2M |
|
5
Sutro Biopharma
STRO
$72.7M
| $3.25M | 1.88% | 175,000 | – | – |
|
|
6
RAPT Therapeutics
RAPT
$188M
| $3.16M | 1.82% | 99,503 -9,000 | -8% | -$286K |
|
|
MTEM
7
DELISTED
Molecular Templates, Inc.
MTEM
| $1.6M | 0.92% | 204,809 | – | – |
|
|
8
Clearside Biomedical
CLSD
$28.9M
| $1.43M | 0.82% | 293,555 -500,000 | -63% | -$2.44M |
|
9
Kezar Life Sciences
KZR
$28.9M
| $700K | 0.4% | 128,916 | – | – |
|
|
RNTX
10
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $647K | 0.37% | 517,558 | – | – |
|
|
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $85K | 0.05% | 25,651 | – | – |
|